Copyright
©The Author(s) 2025.
World J Diabetes. Jun 15, 2025; 16(6): 99602
Published online Jun 15, 2025. doi: 10.4239/wjd.v16.i6.99602
Published online Jun 15, 2025. doi: 10.4239/wjd.v16.i6.99602
Table 3 The observation group is significantly lower than the control group in the incidence of adverse reactions, n (%)
Observation group (n = 66) | Control group (n = 62) | χ2 | P value | |
Dizziness | 3 (4.55) | 4 (6.45) | ||
Nausea | 1 (1.52) | 3 (4.84) | ||
Insomnia | 1 (1.52) | 3 (4.84) | ||
Eye swelling and pain | 0 (0.00) | 4 (6.45) | ||
Total adverse reactions | 5 (7.58) | 14 (22.58) | 5.694 | 0.017 |
- Citation: Long J, Zuo HW. Retroauricular subperiosteal vs systemic intravenous glucocorticoid administration on efficacy and blood glucose in diabetic patients with sudden deafness. World J Diabetes 2025; 16(6): 99602
- URL: https://www.wjgnet.com/1948-9358/full/v16/i6/99602.htm
- DOI: https://dx.doi.org/10.4239/wjd.v16.i6.99602